| scholarly article | Q13442814 |
| P50 | author | David E. Levy | Q39631582 |
| Ricky W Johnstone | Q42384442 | ||
| Daniel J Gough | Q55473952 | ||
| Nicole L Messina | Q56513475 | ||
| P2093 | author name string | Christopher J P Clarke | |
| P2860 | cites work | Immune response in Stat2 knockout mice | Q73406523 |
| Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains | Q73943058 | ||
| IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation | Q77658417 | ||
| Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7 | Q77758397 | ||
| Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection | Q78346749 | ||
| Type I IFN contributes to NK cell homeostasis, activation, and antitumor function | Q80427857 | ||
| Genetic control directed toward spontaneous IFN-alpha/IFN-beta responses and downstream IFN-gamma expression influences the pathogenesis of a murine psoriasis-like skin disease | Q80819716 | ||
| Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 | ||
| Functional role of type I and type II interferons in antiviral defense | Q24276429 | ||
| Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes | Q24295016 | ||
| Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 | ||
| Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model | Q24612339 | ||
| Induction and function of type I and III interferon in response to viral infection | Q27010065 | ||
| How cells respond to interferons | Q27861006 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| The IFN gamma receptor: a paradigm for cytokine receptor signaling | Q28237623 | ||
| Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses | Q28238963 | ||
| Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus | Q28246766 | ||
| Mechanisms of type-I- and type-II-interferon-mediated signalling | Q28247893 | ||
| Type I interferon is selectively required by dendritic cells for immune rejection of tumors | Q28248500 | ||
| Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells | Q69988324 | ||
| Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha | Q71483492 | ||
| Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3 gamma gene using CCAAT/enhancer binding protein-beta(C/EBP-beta) | Q72999285 | ||
| Gene repression by coactivator repulsion | Q73221732 | ||
| A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis | Q28257957 | ||
| Interferons, interferon-like cytokines, and their receptors | Q28293630 | ||
| Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice | Q28594052 | ||
| Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays | Q28646554 | ||
| Stats: transcriptional control and biological impact | Q29547776 | ||
| Paradoxical roles of the immune system during cancer development | Q29614305 | ||
| Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome | Q29616850 | ||
| Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
| Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus | Q33381621 | ||
| Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells | Q33557548 | ||
| Functional crosstalk between type I and II interferon through the regulated expression of STAT1. | Q33570493 | ||
| Structure and function of the interferon-beta enhanceosome | Q33671579 | ||
| A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses | Q33771205 | ||
| Partial impairment of cytokine responses in Tyk2-deficient mice | Q33924660 | ||
| Functional classification of interferon-stimulated genes identified using microarrays | Q33951179 | ||
| Deficiency of the type I interferon receptor protects mice from experimental lupus | Q34016334 | ||
| Mutational switch of an IL-6 response to an interferon-gamma-like response | Q34031049 | ||
| Defining emerging roles for NF-κB in antivirus responses: revisiting the interferon-β enhanceosome paradigm | Q34055270 | ||
| Interferon messenger RNA is produced constitutively in the organs of normal individuals | Q34641073 | ||
| Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses | Q34742996 | ||
| Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection | Q35149011 | ||
| Control of T cell viability | Q35698562 | ||
| Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo | Q35850004 | ||
| IFN-beta in rheumatoid arthritis | Q35880785 | ||
| Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection | Q35978569 | ||
| Normal human epidermis contains an interferon-like protein | Q36215434 | ||
| High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. | Q36228978 | ||
| Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses | Q36315128 | ||
| Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. | Q36369031 | ||
| Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice | Q36497106 | ||
| Biologic Effects of Interferons | Q36612328 | ||
| Interferon-beta1b in multiple sclerosis | Q36752915 | ||
| Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal | Q37076337 | ||
| The transcriptional code of human IFN-beta gene expression | Q37684189 | ||
| Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes | Q37827867 | ||
| Type I interferon in organ-targeted autoimmune and inflammatory diseases | Q37838003 | ||
| Regulation of effector and memory T-cell functions by type I interferon | Q37841676 | ||
| Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice | Q38298730 | ||
| The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50 | Q39587742 | ||
| NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication | Q39683125 | ||
| Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma | Q40514922 | ||
| Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression | Q40741810 | ||
| IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. | Q41038934 | ||
| Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. | Q41071715 | ||
| Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. | Q41082105 | ||
| Is interferon produced in physiologic conditions? | Q41538283 | ||
| Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha/beta genes in acute leukemia cell lines suggests selection against the IFN system | Q41611115 | ||
| Rheumatoid arthritis induced by alpha-interferon therapy | Q41918975 | ||
| GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. | Q42453025 | ||
| Fos and jun proteins are specifically expressed during differentiation of human keratinocytes | Q42472984 | ||
| Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept | Q42479845 | ||
| Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses | Q42488424 | ||
| Distinct requirements for IFNs and STAT1 in NK cell function | Q42494660 | ||
| Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide | Q42499800 | ||
| Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2). | Q42528591 | ||
| Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C. | Q43146940 | ||
| Interferon-beta is required for interferon-alpha production in mouse fibroblasts | Q43412872 | ||
| Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling | Q43688291 | ||
| Effect of exercise on plasma interferon levels | Q44187100 | ||
| IFNalpha activates dormant haematopoietic stem cells in vivo. | Q44358922 | ||
| Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus | Q45736557 | ||
| Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. | Q45988825 | ||
| A critical function for type I interferons in cancer immunoediting | Q46542397 | ||
| IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. | Q52550265 | ||
| Interferon system defects in malignant T-cells. | Q52826947 | ||
| Type I IFN modulates innate and specific antiviral immunity. | Q52920823 | ||
| Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
| STAT3 negatively regulates type I IFN-mediated antiviral response. | Q54356093 | ||
| Critical role for constitutive type I interferon signaling in the prevention of cellular transformation. | Q54503356 | ||
| Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. | Q54664586 | ||
| Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells | Q56881042 | ||
| Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control | Q57055074 | ||
| RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
| Sensitization of IFN-γ Jak-STAT signaling during macrophage activation | Q60595376 | ||
| Type I interferons produced by dendritic cells promote their phenotypic and functional activation | Q61473768 | ||
| The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon | Q68415965 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious disease | Q18123741 |
| P304 | page(s) | 166-74 | |
| P577 | publication date | 2012-02-24 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Constitutive type I interferon modulates homeostatic balance through tonic signaling | |
| P478 | volume | 36 |
| Q28118033 | A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses |
| Q91564570 | A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription |
| Q35568496 | A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis |
| Q33710852 | AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300. |
| Q58701377 | ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols |
| Q39071091 | Absent in Melanoma 2 proteins in SLE. |
| Q36736634 | Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon |
| Q52680802 | Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses. |
| Q38723712 | Alpha/beta interferon receptor deficiency in mice significantly enhances susceptibility of the animals to pseudorabies virus infection |
| Q35927838 | Amplified RLR signaling activation through an interferon-stimulated gene-endoplasmic reticulum stress-mitochondrial calcium uniporter protein loop |
| Q35936773 | Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling |
| Q40085222 | Anti-Cancer Drug HMBA Acts as an Adjuvant during Intracellular Bacterial Infections by Inducing Type I IFN through STING. |
| Q38748641 | Antitumour actions of interferons: implications for cancer therapy |
| Q28394994 | Antiviral regulation in porcine monocytic cells at different activation states |
| Q34745565 | Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. |
| Q36492367 | Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed |
| Q40213573 | Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma |
| Q52371735 | Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. |
| Q47555713 | Blimp-1/PRDM1 is a critical regulator of Type III Interferon responses in mammary epithelial cells |
| Q41807293 | Blockade of chronic type I interferon signaling to control persistent LCMV infection |
| Q92765898 | Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS |
| Q39283180 | Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop. |
| Q34646554 | Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production |
| Q90029966 | CCR2 Signaling Selectively Regulates IFN-α: Role of β-Arrestin 2 in IFNAR1 Internalization |
| Q39128976 | Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses |
| Q36451854 | Cardif (MAVS) Regulates the Maturation of NK Cells |
| Q58091450 | Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during infection |
| Q89000356 | Cell-intrinsic regulation of murine epidermal Langerhans cells by protein S |
| Q36895423 | Changing partners at the dance: Variations in STAT concentrations for shaping cytokine function and immune responses to viral infections |
| Q28487445 | Characterizing the relationship between steady state and response using analytical expressions for the steady states of mass action models |
| Q54112529 | Compound heterozygous TYK2 mutations underlie primary immunodeficiency with T-cell lymphopenia. |
| Q39241252 | Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance |
| Q64937387 | Constitutive Interferon Maintains GBP Expression Required for Release of Bacterial Components Upstream of Pyroptosis and Anti-DNA Responses. |
| Q47094073 | Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells |
| Q28602705 | Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats |
| Q36364287 | Control of the induction of type I interferon by Peste des petits ruminants virus |
| Q35108235 | Critical role of interferon-α constitutively produced in human hepatocytes in response to RNA virus infection |
| Q52648279 | Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. |
| Q39260017 | Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells. |
| Q40561368 | Cutting Edge: Direct Sensing of TLR7 Ligands and Type I IFN by the Common Myeloid Progenitor Promotes mTOR/PI3K-Dependent Emergency Myelopoiesis. |
| Q30381154 | Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes. |
| Q50044861 | Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury. |
| Q40107354 | DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes |
| Q53734706 | Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. |
| Q64899744 | Deficient pulmonary IFN-β expression in COPD patients. |
| Q44657393 | Defined Sensing Mechanisms and Signaling Pathways Contribute to the Global Inflammatory Gene Expression Output Elicited by Ionizing Radiation. |
| Q34651934 | Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse |
| Q38997361 | Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-β. |
| Q37358380 | Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1. |
| Q41944558 | Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs |
| Q34615006 | Differential activity of type I interferon subtypes for dendritic cell differentiation |
| Q40884254 | Distinct immunologic and radiographic patterns in etanercept-induced lung injury |
| Q37565269 | Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin. |
| Q38065485 | Epigenetic regulation of macrophage polarization and function |
| Q91000091 | Epigenetic regulation of macrophages: from homeostasis maintenance to host defense |
| Q27469006 | Expansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversity |
| Q39253678 | Fas-Associated Factor 1 Negatively Regulates the Antiviral Immune Response by Inhibiting Translocation of Interferon Regulatory Factor 3 to the Nucleus |
| Q38591382 | Fine-tuning of type I IFN-signaling in microglia--implications for homeostasis, CNS autoimmunity and interferonopathies |
| Q92535560 | Friend, Foe or Both? Immune Activity in Alzheimer's Disease |
| Q37598937 | GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa. |
| Q35088187 | Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses |
| Q38775242 | Growing tumors induce a local STING dependent Type I IFN response in dendritic cells |
| Q93335194 | HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies |
| Q64125300 | Hes1 attenuates type I IFN responses via VEGF-C and WDFY1 |
| Q27015410 | Host immune response to infection and cancer: unexpected commonalities |
| Q90642181 | Host-Intrinsic Interferon Status in Infection and Immunity |
| Q89119613 | IFN-γ in tissue-immune homeostasis and antitumor immunity |
| Q54201723 | IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice. |
| Q38486383 | IFNA2: The prototypic human alpha interferon. |
| Q36509839 | IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development |
| Q36525884 | IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment |
| Q64971795 | IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response. |
| Q60918283 | ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes |
| Q39077769 | Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING. |
| Q34712064 | Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling |
| Q35145346 | Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations |
| Q38973834 | Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. |
| Q36127624 | Interferon Tau Affects Mouse Intestinal Microbiota and Expression of IL-17. |
| Q91345396 | Interferon target-gene expression and epigenomic signatures in health and disease |
| Q26861003 | Interferon-alpha, immune activation and immune dysfunction in treated HIV infection |
| Q37259195 | Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation |
| Q92860608 | Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation |
| Q34653726 | Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages |
| Q33988567 | Interferons and their stimulated genes in the tumor microenvironment |
| Q89533105 | Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn's disease |
| Q52650219 | Intracellular Antiviral Immunity. |
| Q36813754 | Late stages of T cell maturation in the thymus involve NF-κB and tonic type I interferon signaling |
| Q28602250 | Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases |
| Q28071911 | Lung Involvement in Children with Hereditary Autoinflammatory Disorders |
| Q47875908 | Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells. |
| Q35882034 | Macrophage Polarization in Virus-Host Interactions |
| Q98196886 | Mapping systemic lupus erythematosus heterogeneity at the single-cell level |
| Q35014835 | Meta-analysis identifies NF-κB as a therapeutic target in renal cancer |
| Q41985907 | Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection |
| Q63384050 | NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity |
| Q42710048 | Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons |
| Q37571293 | Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1. |
| Q35617725 | Optineurin regulates the interferon response in a cell cycle-dependent manner |
| Q35944970 | PKR Transduces MDA5-Dependent Signals for Type I IFN Induction |
| Q36550657 | Parsing the Interferon Transcriptional Network and Its Disease Associations |
| Q55278680 | Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses. |
| Q42415022 | Poised for action: USP18 restrains microglial activation in the white matter |
| Q59360964 | Policing the intestinal epithelial barrier: Innate immune functions of intraepithelial lymphocytes |
| Q41999154 | Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons? |
| Q98949264 | Reactive oxygen species oxidize STING and suppress interferon production |
| Q40077623 | Reduced dynamic range of antiviral innate immune responses in aging. |
| Q34625670 | Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling |
| Q38027424 | Refractory celiac disease: from bench to bedside |
| Q39360861 | Regulating STING in health and disease |
| Q39739400 | Regulation of human intestinal T-cell responses by type 1 interferon-STAT1 signaling is disrupted in inflammatory bowel disease |
| Q26853177 | Regulation of type I interferon responses |
| Q61844928 | Relevance of placental type I interferon beta regulation for pregnancy success |
| Q36636150 | Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1 |
| Q39376971 | Responses to Cytokines and Interferons that Depend upon JAKs and STATs |
| Q50130514 | Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice. |
| Q26860434 | Role of KSRP in control of type I interferon and cytokine expression |
| Q90635206 | Role of neuromedin B and its receptor in the innate immune responses against influenza A virus infection in vitro and in vivo |
| Q34804328 | Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes |
| Q42204303 | SCA-1 Expression Level Identifies Quiescent Hematopoietic Stem and Progenitor Cells |
| Q42797555 | STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ. |
| Q28115608 | STAT2 deficiency and susceptibility to viral illness in humans |
| Q102141467 | STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters |
| Q54216757 | STAT2-dependent immune responses ensure host survival despite the presence of a potent viral antagonist. |
| Q40207016 | Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages. |
| Q40875210 | Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing |
| Q27023982 | TLRs and interferons: a central paradigm in autoimmunity |
| Q60046083 | The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor Recruitment |
| Q39076005 | The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils |
| Q28079490 | The Importance of Physiologically Relevant Cell Lines for Studying Virus-Host Interactions |
| Q38773189 | The JAK/STAT pathway in obesity and diabetes |
| Q64099671 | The N-Terminal Domain of cGAS Determines Preferential Association with Centromeric DNA and Innate Immune Activation in the Nucleus |
| Q38097500 | The genetics of innate immunity sensors and human disease |
| Q88873056 | The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis |
| Q34568601 | The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection |
| Q26829387 | The regulation of inflammation by interferons and their STATs |
| Q35046046 | The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. |
| Q36001052 | The role of type I interferons in intestinal infection, homeostasis, and inflammation |
| Q97521710 | Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection? |
| Q36515464 | Tissue-specific interferon alpha subtype response to SIV infection in brain, spleen, and lung |
| Q90266969 | Towards a Better Understanding of Cohesin Mutations in AML |
| Q93115962 | Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases |
| Q37519276 | Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental cerebral malaria |
| Q41079648 | Transmission of innate immune signaling by packaging of cGAMP in viral particles |
| Q101138078 | Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer |
| Q63952479 | Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia |
| Q38744710 | Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota. |
| Q36706302 | Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes |
| Q36569346 | Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. |
| Q38616699 | Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage |
| Q95315174 | Type I Interferons Ameliorate Zinc Intoxication of Candida glabrata by Macrophages and Promote Fungal Immune Evasion |
| Q39241784 | Type I Interferons and Natural Killer Cell Regulation in Cancer |
| Q35053045 | Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia |
| Q39315038 | Type I interferon pathway in CNS homeostasis and neurological disorders. |
| Q45720900 | Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4⁺ T cells. |
| Q48325941 | Type I interferon signaling protects mice from lethal henipavirus infection. |
| Q48221758 | Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9. |
| Q28255842 | Type I interferons in infectious disease |
| Q38851623 | Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis. |
| Q38693735 | Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease |
| Q34025307 | Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. |
| Q58459901 | USP18 establishes the transcriptional and anti-proliferative interferon α/β differential |
| Q35762623 | USP18 lack in microglia causes destructive interferonopathy of the mouse brain |
| Q38916829 | Utilization of different anti-viral mechanisms by mammalian embryonic stem cells and differentiated cells |
| Q64955735 | Variable Baseline Papio cynocephalus Endogenous Retrovirus (PcEV) Expression Is Upregulated in Acutely SIV-Infected Macaques and Correlated to STAT1 Expression in the Spleen. |
| Q36434009 | β-Catenin Upregulates the Constitutive and Virus-Induced Transcriptional Capacity of the Interferon Beta Promoter through T-Cell Factor Binding Sites |
Search more.